Why it matters: The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.
President Biden on Tuesday said that ramped-up coronavirus vaccine production will provide enough doses for 300 million Americans by the end May.
Why it matters: That's two months sooner than Biden's previous promise of enough vaccines for all American adults by the end of July.
Texas will end its coronavirus restrictions next week with an upcoming executive order, Gov. Greg Abbott (R) announced Tuesday during a press conference in Lubbock.
Why it matters: After Abbott signs the new order, which rescinds previous orders, all businesses can open to 100% capacity and the statewide mask mandate will be over, though large parts of the state will remain under mask local ordinances.
President Biden will announce Tuesday that pharmaceutical giant Merck will help Johnson & Johnson manufacture its newly authorized coronavirus vaccine to boost supply, a senior administration official tells Axios.
The big picture: The development has the potential to vastly increase supply, possibly doubling what the J&J could make on its own, the official said. The company has run into challenges while trying to expand its vaccine production to a global scale.
Vaccine hesitancy is fading, according to a poll of six countries shared with Axios by strategic consulting firm Kekst CNC.
Zoom in: Brits have embraced the national vaccination mission, with a whopping 89% willing to be vaccinated.
A new initiative — funded by DARPA, the Pentagon's high-tech research arm — is aiming to make it much easier to scale up the next generation of RNA- and DNA-based vaccines.
Driving the news: A consortium including GE Research, the Broad Institute and the University of Washington is announcing today that it's secured a $41 million grant from DARPA.
Teenagers' demand for mental health care skyrocketed last year amid the pandemic, even as their overall need for care declined, according to a new analysis by FAIR Health.
Why it matters: Parents, schools and pediatricians have been warning for months that kids aren't OK, and this analysis backs up their concern with numbers.
During the last year, Americans have felt stressed out and worried about the coronavirus — but now more say they're hopeful as the vaccines become available, according to the latest installment of the Axios/Ipsos Coronavirus Index.
The big picture: Americans finally see some light at the end of the tunnel as we approach the one-year anniversary of the national emergency over the pandemic — a year that has been full of misery, mental anguish, and sickness and death here and around the world.
Only the biggest subsidies through the Affordable Care Act improved families' overall financial well-being, according to a study published Monday in Health Affairs.
The big picture: Low-income families eligible for both premium subsidies and cost-sharing subsidies spent 17% less on out-of-pocket health care costs than unsubsidized enrollees. But the financial burden of health care costs didn't alleviate at all for middle-income families eligible only for premium subsdies.
Several countries in the Americas have received their first vaccine shipments over the past few weeks — not from the regional superpower or from Western pharmaceutical giants, but from China, Russia, and in some cases India.
Why it matters: North and South America have been battered by the pandemic and recorded several of the world’s highest death tolls. Few countries other than the U.S. have the capacity to manufacture vaccines at scale, and most lack the resources to buy their way to the front of the line for imports. That’s led to a scramble for whatever supply is available.